231 related articles for article (PubMed ID: 800772)
1. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
Costa AL; Valenti A; Costa G; Calogero F
G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
Strippoli V; Torosantucci A; Simonetti N
Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
[TBL] [Abstract][Full Text] [Related]
3. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
Böhm W
Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
[No Abstract] [Full Text] [Related]
4. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies on synergistic antifungal activity.
Shadomy S
Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
[No Abstract] [Full Text] [Related]
6. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Ellis NS; Bartlett MS; Smith JW
Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
[TBL] [Abstract][Full Text] [Related]
7. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
Chin CS; Cheong YM; Wong YH
Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Hoeprich PD; Huston AC
J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
[TBL] [Abstract][Full Text] [Related]
9. Letter: Amphotericin B and 5-fluorocytosine.
Medoff G; Kobayashi GS
J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
[No Abstract] [Full Text] [Related]
10. Treatment of fungal infections with flucytosine.
Harder EJ; Hermans PE
Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between in vitro and in vivo antifungal activity of albendazole.
Hardin TC; Najvar LK; Rizzo J; Fothergill AW; Rinaldi MG; Graybill JR
J Med Vet Mycol; 1997; 35(3):153-8. PubMed ID: 9229330
[TBL] [Abstract][Full Text] [Related]
12. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
Hamilton JD; Elliott DM
J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
[TBL] [Abstract][Full Text] [Related]
13. Activity of phenothiazines against medically important yeasts.
Eilam Y; Polacheck I; Ben-Gigi G; Chernichovsky D
Antimicrob Agents Chemother; 1987 May; 31(5):834-6. PubMed ID: 3300543
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
Utz CJ; Shadomy S
J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
[TBL] [Abstract][Full Text] [Related]
15. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
16. The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.
Polak A; Wain WH
Chemotherapy; 1977; 23(4):243-59. PubMed ID: 324722
[TBL] [Abstract][Full Text] [Related]
17. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
Polak A
Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
[No Abstract] [Full Text] [Related]
18. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
Pankey GA; Lockwood WR; Montalvo JM
J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
[No Abstract] [Full Text] [Related]
19. New small-size peptides possessing antifungal activity.
Garibotto FM; Garro AD; Masman MF; Rodríguez AM; Luiten PG; Raimondi M; Zacchino SA; Somlai C; Penke B; Enriz RD
Bioorg Med Chem; 2010 Jan; 18(1):158-67. PubMed ID: 19959366
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
Gadebusch HH; Pansy F; Klepner C; Schwind R
J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
